Triphalax
Food supplement declared in France, decision dated 6 February 2026
Triphalax (Medenda) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Medenda
- Food business operator placing the product on the market
- ESE group
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 à 4 gélules paer jour à prendre le soir au coucher
- Directions for use
- 2 à 4 gélules paer jour à prendre le soir au coucher
- Intended populations
- Population générale
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit, Digestion
Declaration 88145, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Terminalia chebula Retz. | Fruit | Autre extrait sec | 666.66 mg |
| Terminalia bellerica (Gaertn.) Roxb. | Fruit | Autre extrait sec | 666.66 mg |
| Phyllanthus emblica L. | Fruit | Autre extrait sec | 666.66 mg |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Medenda